Your browser doesn't support javascript.
loading
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.
Vincenti, Flavio; Fervenza, Fernando C; Campbell, Kirk N; Diaz, Montserrat; Gesualdo, Loreto; Nelson, Peter; Praga, Manuel; Radhakrishnan, Jai; Sellin, Lorenz; Singh, Ajay; Thornley-Brown, Denyse; Veronese, Francisco Veríssimo; Accomando, Beverly; Engstrand, Sara; Ledbetter, Steven; Lin, Julie; Neylan, John; Tumlin, James.
Afiliação
  • Vincenti F; University of California, San Francisco, San Francisco, California, USA.
  • Fervenza FC; Mayo Clinic, Rochester, Minnesota, USA.
  • Campbell KN; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Diaz M; Fundació Puigvert, Barcelona, Spain.
  • Gesualdo L; Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, U.O.C Nefrologia, Dialisi e Trapianto, Bari, Italy.
  • Nelson P; University of Washington, Seattle, Washington, USA.
  • Praga M; Complutense University, Investigation Institute Hospital 12 de Octubre, Madrid, Spain.
  • Radhakrishnan J; Columbia University Medical Center, New York, New York, USA.
  • Sellin L; Klinik für Nephrologie, Universitätsklinikum Düsseldorf, Medical School, Düsseldorf, Germany.
  • Singh A; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Thornley-Brown D; University of Alabama at Birmingham, Alabama, USA.
  • Veronese FV; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Accomando B; Sanofi, Cambridge, Massachusetts, USA.
  • Engstrand S; Sanofi, Cambridge, Massachusetts is the former affiliation of SE, SL, JL, and JN.
  • Ledbetter S; Sanofi, Cambridge, Massachusetts is the former affiliation of SE, SL, JL, and JN.
  • Lin J; Sanofi, Cambridge, Massachusetts is the former affiliation of SE, SL, JL, and JN.
  • Neylan J; Sanofi, Cambridge, Massachusetts is the former affiliation of SE, SL, JL, and JN.
  • Tumlin J; University of Tennessee College of Medicine, Chattanooga, Tennessee, USA.
Kidney Int Rep ; 2(5): 800-810, 2017 Sep.
Article em En | MEDLINE | ID: mdl-29270487
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Kidney Int Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Kidney Int Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos